The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision-Reference-Cited by-同舟云学术

The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision

Published:2020-06 Issue:6 Volume:46 Page:1118-1123
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Wang Xiaojie,Chen Guangliang,Zhang Yiyi,Ghareeb Waleed M.,Yu Qian,Zhu Heyuan,Lu Xingrong,Huang Ying,Huang Shenghui,Hou Dan,Chi Pan

Funder

National Clinical Key Specialty Construction Project (General Surgery) of China

National Natural Science Foundation of China

Young Scientist Foundation of Fujian Provincial Commission of Health and Family Planning

Startup Fund for Scientific Research

Fujian Medical University

Joint Funds for the Innovation of Science and Technology, Fujian province

Fujian Science and Technology

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference32 articles.

1. Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer;VC;Acta oncol. (Stockholm, Sweden),2019

2. Local recurrence of rectal cancer in patients not receiving neoadjuvant therapy – the importance of resection margins;Dassanayake;Ceylon Med J,2011

3. The influence of circumferential resection margins on survival following rectal cancer surgery;Mois,2017

4. Does circumferential tumor location affect the circumferential resection margin status in mid and low rectal cancer?;Kang;Asian J Surg,2017

5. Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour;Chan;Br J Surg,2010

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Indispensable Roles of GMDS and GMDS-AS1 in the Advancement of Cancer: Fucosylation, Signal Pathway and Molecular Pathogenesis;Mini-Reviews in Medicinal Chemistry;2024-10

2. PRCNet: A parallel reverse convolutional attention network for colorectal polyp segmentation;Biomedical Signal Processing and Control;2024-09

3. Polymeric nanoparticles as delivery vehicles for targeted delivery of chemotherapy drug fludarabine to treat hematological cancers;Inorganic Chemistry Communications;2024-09

4. GMI-based biosensor for the detection and quantification of doxorubicin anticancer drugs labeled to Fe3O4 superparamagnetic nanoparticles;Sensors and Actuators A: Physical;2024-08

5. lncRNAs: New players of cancer drug resistance via targeting ABC transporters;IUBMB Life;2024-08